Bentley Pharmaceuticals to Announce Second Quarter 2007 Financial Results and Conduct a Conference Call on August 2, 2007

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today announced that management will host a conference call to discuss second quarter results and provide a business update on Thursday, August 2, 2007, at 10:00 A.M. (Eastern Time). Bentley will release its results for the three and six months ended June 30, 2007, before the open of the market on that day.

To participate on the live call, please dial (888) 332-7254 from the U.S. and Canada or, for international callers, please dial (973) 582-2856. The access code for this call is 8987783. Please dial in approximately 10 minutes prior to the scheduled start time. The conference call will also be broadcast live on the Internet and may be accessed via Bentley’s web site, www.bentleypharm.com.

A telephone replay will be available for 30 days by dialing (877) 519-4471 from the U.S. and Canada or (973) 341-3080 for international callers. Please reference reservation number 8987783. A replay of the conference call will also be available on Bentley’s web site for 30 days.

Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and generic pharmaceutical products. Bentley’s proprietary drug delivery technologies enhance the absorption of pharmaceutical compounds across various membranes. Bentley manufactures and markets a growing portfolio of generic and branded generic pharmaceuticals in Europe for the treatment of cardiovascular, gastrointestinal, infectious and central nervous system diseases through its subsidiaries — Laboratorios Belmac, Laboratorios Davur, Laboratorios Rimafar and Bentley Pharmaceuticals Ireland. Bentley also manufactures and markets active pharmaceutical ingredients through its subsidiary, Bentley API.

Additional information regarding Bentley Pharmaceuticals may be obtained through Bentley’s web site at www.bentleypharm.com.